Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Herman

Showing results (51-60 of 259) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagusMingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics|May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancerWenji Yan, Kongming Wu, James G Herman, et al.
Epigenomics|April 14, 2017
Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancerTao He, Meiying Zhang, Ruipan Zheng, et al.
Cancer Science|May 1, 2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancerWushuang Du, Aiai Gao, James G Herman, et al.
Annals of Hematology|October 19, 2005
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemiaOliver Galm, Stefan Wilop, Christian Lüders, et al.
Journal of Neuro-Oncology|December 14, 2006
Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiformeRamon Martinez, Gabriele Schackert, Ricard Yaya-Tur, et al.
Clinical Epigenetics|November 8, 2018
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinomaHongxia Li, Meiying Zhang, Enqiang Linghu, et al.
Journal of Translational Internal Medicine|July 31, 2024
Methylation of <i>FAM110C</i> is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancerFengna Liu, Aiai Gao, Meiying Zhang, et al.
Discovery Medicine|October 9, 2013
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasionBaoping Cao, Yunsheng Yang, Yuanming Pan, et al.
Discovery Medicine|December 10, 2015
Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancerTenghui Dong, Meiying Zhang, Yan Dong, et al.
Pageof 26

Showing results (51-60 of 259) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagusMingzhou Guo, Jingli Ren, Michael G House, et al.
Clinical Epigenetics|May 26, 2018
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancerWenji Yan, Kongming Wu, James G Herman, et al.
Epigenomics|April 14, 2017
Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancerTao He, Meiying Zhang, Ruipan Zheng, et al.
Cancer Science|May 1, 2021
Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancerWushuang Du, Aiai Gao, James G Herman, et al.
Annals of Hematology|October 19, 2005
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemiaOliver Galm, Stefan Wilop, Christian Lüders, et al.
Journal of Neuro-Oncology|December 14, 2006
Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiformeRamon Martinez, Gabriele Schackert, Ricard Yaya-Tur, et al.
Clinical Epigenetics|November 8, 2018
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinomaHongxia Li, Meiying Zhang, Enqiang Linghu, et al.
Journal of Translational Internal Medicine|July 31, 2024
Methylation of <i>FAM110C</i> is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancerFengna Liu, Aiai Gao, Meiying Zhang, et al.
Discovery Medicine|October 9, 2013
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasionBaoping Cao, Yunsheng Yang, Yuanming Pan, et al.
Discovery Medicine|December 10, 2015
Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancerTenghui Dong, Meiying Zhang, Yan Dong, et al.
Pageof 26